Detection of a moderate staphylococcal phage by means of antineoplastic agents
Smolianskaia, A.Z.; Leĭkina, F.I.
Antibiotiki 15(6): 514-519
1970
ISSN/ISBN: 0003-5637 PMID: 4195833 Document Number: 29516
Document emailed within 1 workday
Related Documents
Babkov, V.V.; Borisov, L.B. 1977: Phage conversion of the antigens in Escherichiae and Shigellae. 2. Conversion of the somatic antigen in Shigella flexneri with the moderate E. coli 0129 phage Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 86-89Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839
Ishii, T.; Yokoyama, T.; Kishi, D. 1975: Application of staphylococcal phage typing to clinical epidemiology Rinsho Byori. Japanese Journal of Clinical Pathology 23(8): 594-598
Vinnikov, A.I.; Kozlova, N.S.; Babenko, I.S.; Zueva, V.S. 1986: Action of inhibitors of the energy processes on the efficiency of staphylococcal phage infection Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 9: 33-35
Kishko, I.G.; Ruban, V.I.; Tovkach, F.I.; Murashchik, I.G. 1982: Electron microscopic structure of Erwinia carotovora moderate phage 59 and its DNA Voprosy Virusologii 27(3): 348-354
Kishko, I.G.; Ruban, V.I.; Tovkach, F.I.; Murashchik, I.G. 1982: Electron microscopic structure of Erwinia carotovora moderate phage 59 and its DNA Voprosy Virusologii 27(3): 348-354
Curran, J.P.; Al-Salihi, F.L. 1980: Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type Pediatrics 66(2): 285-290
Kiseleva, N.P.; Zinchenko, A.I.; Khromov, I.S.; Tikhonenko, T.I. 1977: Identification of CD phage proteins participating in DNA-protein interaction by means of O-methylhydroxylamine Biokhimiia 42(6): 1090-1096
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Babaian, I.S.; Khudaverdian, N.V.; Karapetian, L.G.; Kazarian, R.S.; Sogomonian, L.R. 1997: Comparative study of three antineoplastic alkylating agents on DNA Biofizika 42(2): 542-543
Matsumura, Y. 1982: Intravesical instillation of adriamycin and other antineoplastic agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 372-376
Takeuchi, A. 1980: Bronchial artery infusion of antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 38(7): 2683-2690
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3
Orfi, L.; Wáczek, F.; Szabó, M.; Kövesdi, I.; Mészáros, G.; Idei, M.; Horváth, A.; Hollósy, F.; Mák, M.; Szegedi, Z.; Szende, B.; Kéri, G.; Noszál, B. 1999: Preparation and characterization of potential antineoplastic agents Acta Pharmaceutica Hungarica 69(3): 115-122